Stachydrine derived from fermented rice prevents diet-induced obesity by regulating adipsin and endoplasmic reticulum homeostasis

J Nutr Biochem. 2022 Sep:107:109036. doi: 10.1016/j.jnutbio.2022.109036. Epub 2022 May 6.

Abstract

Makgeolli, a widely consumed traditional alcoholic beverage in Korea, is brewed mainly from rice using Nuruk as a fermentation starter, which contains fungi, yeast, and lactic acid bacteria. Among 58 Makgeolli samples brewed using various Nuruks, we found that one exhibited anti-obesity properties, with stachydrine shown to be responsible for these properties. Stachydrine promotes lipolysis and inhibits lipid accumulation in 3T3-L1 adipocytes; it also reduces weight gain and improves glucose tolerance and insulin resistance in a mouse model. Stachydrine dramatically suppresses adipsin mRNA levels in liver and adipose tissue, whereas serum adipsin levels were elevated in stachydrine-treated mice compared to mice fed a high-fat diet alone. Moreover, stachydrine recovers endoplasmic reticulum homeostasis and regulates adipsin expression. We highlight the potential use of stachydrine as a therapeutic agent for the treatment of obesity and insulin resistance and the use of Makgeolli fermented by Nuruk as a source of novel bioactive compounds.

Keywords: Adipsin; Antiobesity; Fermented rice; Makgeolli; Nuruk; Stachydrine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Animals
  • Complement Factor D / therapeutic use
  • Diet, High-Fat / adverse effects
  • Endoplasmic Reticulum / metabolism
  • Homeostasis
  • Insulin Resistance*
  • Mice
  • Mice, Inbred C57BL
  • Obesity / etiology
  • Obesity / prevention & control
  • Oryza*
  • Proline / analogs & derivatives

Substances

  • Proline
  • Complement Factor D
  • stachydrine